Marshall Wace North America’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-83,826
| Closed | -$751K | – | 1447 |
|
|
2020
Q2 | $751K | Sell |
83,826
-182,858
| -69% | -$1.64M | 0.01% | 842 |
|
|
2020
Q1 | $1.7M | Buy |
266,684
+235,338
| +751% | +$1.5M | 0.01% | 517 |
|
|
2019
Q4 | $263K | Sell |
31,346
-1,000,468
| -97% | -$8.39M | ﹤0.01% | 920 |
|
|
2019
Q3 | $9.34M | Buy |
+1,031,814
| New | +$9.34M | 0.05% | 270 |
|
|
2019
Q1 | – | Sell |
-22,086
| Closed | -$254K | – | 1869 |
|
|
2018
Q4 | $254K | Buy |
+22,086
| New | +$254K | ﹤0.01% | 914 |
|
|
2013
Q3 | – | Sell |
-11,701
| Closed | -$91K | – | 696 |
|
|
2013
Q2 | $91K | Buy |
+11,701
| New | +$91K | 0.01% | 413 |
|